Long-Mira, E.; Bontoux, C.; Rignol, G.; Hofman, V.; Lassalle, S.; Benzaquen, J.; Boutros, J.; Lalvée-Moret, S.; Zahaf, K.; Lespinet-Fabre, V.;
et al. Exploring the Expression of CD73 in Lung Adenocarcinoma with EGFR Genomic Alterations. Cancers 2025, 17, 1034.
https://doi.org/10.3390/cancers17061034
AMA Style
Long-Mira E, Bontoux C, Rignol G, Hofman V, Lassalle S, Benzaquen J, Boutros J, Lalvée-Moret S, Zahaf K, Lespinet-Fabre V,
et al. Exploring the Expression of CD73 in Lung Adenocarcinoma with EGFR Genomic Alterations. Cancers. 2025; 17(6):1034.
https://doi.org/10.3390/cancers17061034
Chicago/Turabian Style
Long-Mira, Elodie, Christophe Bontoux, Guylène Rignol, Véronique Hofman, Sandra Lassalle, Jonathan Benzaquen, Jacques Boutros, Salomé Lalvée-Moret, Katia Zahaf, Virginie Lespinet-Fabre,
and et al. 2025. "Exploring the Expression of CD73 in Lung Adenocarcinoma with EGFR Genomic Alterations" Cancers 17, no. 6: 1034.
https://doi.org/10.3390/cancers17061034
APA Style
Long-Mira, E., Bontoux, C., Rignol, G., Hofman, V., Lassalle, S., Benzaquen, J., Boutros, J., Lalvée-Moret, S., Zahaf, K., Lespinet-Fabre, V., Bordone, O., Maistre, S., Bonnetaud, C., Cohen, C., Berthet, J.-P., Marquette, C.-H., Vouret-Craviari, V., Ilié, M., & Hofman, P.
(2025). Exploring the Expression of CD73 in Lung Adenocarcinoma with EGFR Genomic Alterations. Cancers, 17(6), 1034.
https://doi.org/10.3390/cancers17061034
